Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 2
1963 2
1964 2
1965 1
1966 1
1967 3
1968 1
1969 7
1970 3
1972 3
1973 1
1974 1
1975 4
1976 2
1977 1
1978 4
1979 5
1980 3
1981 4
1982 7
1983 5
1984 4
1985 7
1986 19
1987 11
1988 18
1989 21
1990 24
1991 21
1992 31
1993 16
1994 15
1995 24
1996 25
1997 22
1998 19
1999 22
2000 32
2001 25
2002 21
2003 27
2004 21
2005 27
2006 10
2007 17
2008 26
2009 25
2010 15
2011 19
2012 28
2013 33
2014 40
2015 39
2016 43
2017 41
2018 37
2019 35
2020 35
2021 32
2022 33
2023 34
2024 43
2025 35

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,046 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis and management of paroxysmal nocturnal hemoglobinuria.
Parker C, Omine M, Richards S, Nishimura J, Bessler M, Ware R, Hillmen P, Luzzatto L, Young N, Kinoshita T, Rosse W, Socié G; International PNH Interest Group. Parker C, et al. Among authors: nishimura j. Blood. 2005 Dec 1;106(12):3699-709. doi: 10.1182/blood-2005-04-1717. Epub 2005 Jul 28. Blood. 2005. PMID: 16051736 Free PMC article. Review. No abstract available.
Commentary: Tick-tock.
Nishimura J, Mokadam NA. Nishimura J, et al. J Thorac Cardiovasc Surg. 2021 Jul;162(1):68-69. doi: 10.1016/j.jtcvs.2020.01.027. Epub 2020 Jan 31. J Thorac Cardiovasc Surg. 2021. PMID: 32087953 Free article. No abstract available.
The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria.
Röth A, Nishimura JI, Nagy Z, Gaàl-Weisinger J, Panse J, Yoon SS, Egyed M, Ichikawa S, Ito Y, Kim JS, Ninomiya H, Schrezenmeier H, Sica S, Usuki K, Sicre de Fontbrune F, Soret J, Sostelly A, Higginson J, Dieckmann A, Gentile B, Anzures-Cabrera J, Shinomiya K, Jordan G, Biedzka-Sarek M, Klughammer B, Jahreis A, Bucher C, Peffault de Latour R. Röth A, et al. Among authors: nishimura ji. Blood. 2020 Mar 19;135(12):912-920. doi: 10.1182/blood.2019003399. Blood. 2020. PMID: 31978221 Free PMC article. Clinical Trial.
Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition.
Röth A, He G, Tong H, Lin Z, Wang X, Chai-Adisaksopha C, Lee JH, Brodsky A, Hantaweepant C, Dumagay TE, Demichelis-Gómez R, Rojnuckarin P, Sun J, Höglund M, Jang JH, Gaya A, Silva F, Obara N, Kelly RJ, Beveridge L, Buatois S, Chebon S, Gentile B, Lundberg P, Sreckovic S, Nishimura JI, Risitano A, Han B. Röth A, et al. Among authors: nishimura ji. Am J Hematol. 2024 Sep;99(9):1768-1777. doi: 10.1002/ajh.27412. Epub 2024 Jun 17. Am J Hematol. 2024. PMID: 38884175 Free article. Clinical Trial.
Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers.
Saito T, Nishikawa H, Wada H, Nagano Y, Sugiyama D, Atarashi K, Maeda Y, Hamaguchi M, Ohkura N, Sato E, Nagase H, Nishimura J, Yamamoto H, Takiguchi S, Tanoue T, Suda W, Morita H, Hattori M, Honda K, Mori M, Doki Y, Sakaguchi S. Saito T, et al. Among authors: nishimura j. Nat Med. 2016 Jun;22(6):679-84. doi: 10.1038/nm.4086. Epub 2016 Apr 25. Nat Med. 2016. PMID: 27111280
Long-term efficacy and safety of danicopan as add-on therapy to ravulizumab or eculizumab in PNH with significant EVH.
Kulasekararaj A, Griffin M, Piatek C, Shammo J, Nishimura JI, Patriquin C, Schrezenmeier H, Barcellini W, Panse J, Gaya A, Patel Y, Liu P, Filippov G, Sicre de Fontbrune F, Risitano A, Lee JW. Kulasekararaj A, et al. Among authors: nishimura ji. Blood. 2025 Feb 20;145(8):811-822. doi: 10.1182/blood.2024026299. Blood. 2025. PMID: 39700502 Free PMC article. Clinical Trial.
Two cases of protein-losing enteropathy induced by zolbetuximab in patients with unresectable advanced gastric cancer.
Yanagimoto Y, Yamamoto K, Hara K, Masuike Y, Ushimaru Y, Kitamura M, Honma K, Matsuura N, Sugase T, Kanemura T, Mori R, Kitakaze M, Amisaki M, Kubo M, Mukai Y, Komatsu H, Sueda T, Kagawa Y, Nishimura J, Wada H, Goto K, Yasui M, Omori T, Miyata H. Yanagimoto Y, et al. Among authors: nishimura j. Jpn J Clin Oncol. 2025 Jul 6;55(7):825-831. doi: 10.1093/jjco/hyaf055. Jpn J Clin Oncol. 2025. PMID: 40194315
Genetic variants in C5 and poor response to eculizumab.
Nishimura J, Yamamoto M, Hayashi S, Ohyashiki K, Ando K, Brodsky AL, Noji H, Kitamura K, Eto T, Takahashi T, Masuko M, Matsumoto T, Wano Y, Shichishima T, Shibayama H, Hase M, Li L, Johnson K, Lazarowski A, Tamburini P, Inazawa J, Kinoshita T, Kanakura Y. Nishimura J, et al. N Engl J Med. 2014 Feb 13;370(7):632-9. doi: 10.1056/NEJMoa1311084. N Engl J Med. 2014. PMID: 24521109 Free article.
Commentary: Just because we can doesn't mean we should.
Nishimura J, Mokadam NA. Nishimura J, et al. J Thorac Cardiovasc Surg. 2020 Jun;159(6):2324-2325. doi: 10.1016/j.jtcvs.2019.07.049. Epub 2019 Jul 26. J Thorac Cardiovasc Surg. 2020. PMID: 31420132 Free article. No abstract available.
1,046 results